JP2011036416A - Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone - Google Patents

Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone Download PDF

Info

Publication number
JP2011036416A
JP2011036416A JP2009186569A JP2009186569A JP2011036416A JP 2011036416 A JP2011036416 A JP 2011036416A JP 2009186569 A JP2009186569 A JP 2009186569A JP 2009186569 A JP2009186569 A JP 2009186569A JP 2011036416 A JP2011036416 A JP 2011036416A
Authority
JP
Japan
Prior art keywords
pulse
subject
cell function
biological cell
body temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009186569A
Other languages
Japanese (ja)
Inventor
Takashi Omori
隆史 大森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2009186569A priority Critical patent/JP2011036416A/en
Publication of JP2011036416A publication Critical patent/JP2011036416A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for evaluating a biological cell function which simply evaluates a pathosis simply from the condition of a patient who has not become ill yet. <P>SOLUTION: The method for evaluation is characterized in that: the pulse of the patient is measured; the temperature of the patient is measured at the same time when with the pulse is measured; the value given by dividing the pulse by the temperature is obtained; and the pathosis is evaluated from the condition of the patient who has not become ill yet on the basis of the value. The patient measures by himself or herself the pulse and the temperature using a measuring instrument, detects myocardial infarction and/or cerebral infarction which are ischemic change in the patient's body and infection and/or an autoimmune disease which are inflammatory reaction in the patient's body, and transmits alarm information to the patient. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、被験者における未病状態から病的状態を簡易に評価する生体細胞機能の評価方法に関する。   The present invention relates to a biological cell function evaluation method for simply evaluating a pathological state from a non-disease state in a subject.

人間を初めとする生物は一個の細胞をスタートとして、細胞数を増やして組織となり、さらに生命ある個体として成長していく。生体活動の基本である細胞では、外部から供給される栄養素(炭水化物、脂質、蛋白質、ビタミン、ミネラルなど)を利用して様々な生化学反応を行っている。
炭水化物やタンパク質などは高分子化合物であり、これを分解(消化)して吸収するためには独自の酵素タンパク質が必要である。この酵素タンパク質には鉄、マグネシウムなどのミネラルが必要な場合があり、さらに補助的な役割としてビタミンを必要とすることが多い。
Human beings and other organisms start with a single cell, increase the number of cells to become an organization, and grow as a living individual. Cells, which are the basis of biological activities, carry out various biochemical reactions using nutrients (carbohydrates, lipids, proteins, vitamins, minerals, etc.) supplied from the outside.
Carbohydrates and proteins are high molecular compounds, and in order to decompose (digest) and absorb them, unique enzyme proteins are required. This enzyme protein may require minerals such as iron and magnesium, and often requires vitamins as an auxiliary role.

炭水化物はアミラーゼなどによって分解されてブドウ糖になる。このブドウ糖は細胞内基質やミトコンドリアで、ブドウ糖から最終的にエネルギー蓄積化合物であるATPに変換される。このATPは様々な細胞活動に利用されるが、一部はタンパク質からアミノ酸までの分解と、アミノ酸を人間の体に合ったタンパク質合成のためのエネルギー源となる。新しく合成されるタンパク質は酵素、細胞構成要素、筋肉、皮膚、骨などに利用される。   Carbohydrates are broken down into glucose by amylase. This glucose is finally converted from glucose into ATP, which is an energy storage compound, by intracellular substrates and mitochondria. This ATP is used for various cellular activities, but part of it is an energy source for protein degradation to amino acids and protein synthesis that matches amino acids with the human body. Newly synthesized proteins are used for enzymes, cellular components, muscles, skin, bones, etc.

また、脂質は細胞膜を構成するために利用される。脂質二重膜によって細胞の内外が仕切られ、閉鎖空間としての細胞が構築される。その脂質二重膜の間にタンパク質が組み込まれ、物質輸送や情報伝達という細胞膜の機能が高まる。
細胞を基本として生命活動が営まれ、組織、生体という統合体は日々活動を行うことになる。体外から取り入れた物質を基にして、各臓器の細胞で種々の栄養素を代謝処理する過程で代謝産物が血液中に増える。代謝産物は肝臓などの臓器で処理され、老廃物として肝臓や腎臓で排泄される。
Lipids are also used to form cell membranes. The inside and outside of the cell are partitioned by the lipid bilayer membrane, and the cell as a closed space is constructed. Proteins are incorporated between the lipid bilayers, and the functions of cell membranes such as mass transport and information transmission are enhanced.
Life activities are carried out on the basis of cells, and the integrated body of tissues and living bodies performs activities every day. Based on substances taken from outside the body, metabolites increase in the blood in the process of metabolizing various nutrients in cells of each organ. Metabolites are processed in organs such as the liver and excreted as waste products in the liver and kidneys.

生体組織の活動が正常に行われている時には、血液中の代謝産物の濃度は基準範囲内にある。さらに、細胞の老化に伴って、細胞の再構築の際に壊された古い細胞からの細胞質内の酵素などは、常に一定量血液中に放出される。これら血液中の化学物質の濃度や酵素タンパク質の酵素活性などを測定することによって、生体活動の状態の把握ができる。生体の細胞は生命を維持するために、恒常性という自動調節機能が働いていて、各生化学物質の濃度や酵素活性などは、一定の基準範囲に調節されている。   When living tissue activity is normal, the concentration of metabolites in the blood is within the reference range. Furthermore, with the aging of cells, enzymes in the cytoplasm from old cells that have been destroyed during cell remodeling are always released into the blood in a certain amount. By measuring the concentration of chemical substances in the blood, enzyme activity of enzyme proteins, and the like, the state of biological activity can be grasped. In order to maintain the life of living cells, an automatic regulation function called homeostasis works, and the concentration and enzyme activity of each biochemical substance are adjusted to a certain reference range.

医療現場で行われる血液検査などは、このような生化学反応の変化を検知するために行われている。さらに、臓器レベルの変化が起こってきた場合は心電図、レントゲン写真、CT、MRIさらにはPETなどを利用して、生体内の変化を捉えようとしている。種々の検査を組み合わせることによって、生体に生じた異常事態の状況把握、さらに原因までを追究して治療につなげる取り組みが行われる。現代医学はこのような方法論を基に発展してきた。   Blood tests and the like performed at medical sites are performed to detect such changes in biochemical reactions. Furthermore, when changes in the organ level occur, an attempt is made to capture changes in the living body by using an electrocardiogram, an X-ray photograph, CT, MRI or PET. By combining various tests, efforts are made to grasp the status of abnormal situations that have occurred in the living body and to investigate the cause and lead to treatment. Modern medicine has been developed based on this methodology.

しかし、これらの検査などを実施できる場所は、場合によっては、在宅往診で行えることもあるが、基本的には医療施設内に限られることが大半である。
現在、日本国内では様々な医療制度に矛盾が生じ、医療崩壊が深刻になっている。医師数不足で病院閉鎖が確実に増加している。医療費が高騰する一方で、経済不況に伴って医療機関を受診できない人々も増加している。今後、高齢化社会が広がっていく過程で、医療現場の崩壊は医療の質の低下を招く危険を孕んでいる。
However, in some cases, these examinations can be performed at home, but in most cases they are basically limited to medical facilities.
Currently, there are contradictions in various medical systems in Japan, and medical collapse has become serious. Hospital closures are steadily increasing due to a shortage of doctors. While medical costs have soared, an increasing number of people are unable to visit medical institutions due to the economic recession. In the future, as the aging society expands, the collapse of the medical field entails the danger of reducing the quality of medical care.

また、以前から成人病、生活習慣病と名づけて予防を呼びかけて来た高血圧、糖尿病、高脂血症などは、今なお増加を続けている。昨年からはメタボリック症候群というキャッチフレーズで国民の意識変革を狙っている。この間、10年以上は経過しているが、未だに脳梗塞、心筋梗塞の発症は減るどころか増加している。
脳梗塞、心筋梗塞は発症してから、救急病院を始めとするある程度の規模の病院を受診することが基本となっている。この段階では、それまでの医療費に比べ、短期間で高額の医療費が発生することが少なくない。このような状況を回避しようと、事前に健康診断などが実施されているが、急性期の変化に対応できる取り組みにはなっていない。
In addition, hypertension, diabetes, hyperlipidemia, etc., which have been called adult diseases and lifestyle-related diseases for a long time, have continued to increase. Since last year, the aim is to change the public awareness with the catchphrase of metabolic syndrome. During this time, more than 10 years have passed, but the incidence of cerebral infarction and myocardial infarction is still increasing.
After cerebral infarction and myocardial infarction have developed, it is fundamental to visit hospitals of a certain scale, including emergency hospitals. At this stage, it is often the case that a large amount of medical expenses are generated in a short period of time compared to the medical expenses until then. In order to avoid such a situation, medical examinations are conducted in advance, but it is not an approach that can cope with changes in the acute phase.

この状況の中で、何らかの重症の急性期状態になる少し前に、できる限り簡単な方法で異常の前兆を察知できる方法を確立することが必要である。
そこで、従来、耳の中に測定器を挿入し、耳穴の皮膚に波長の異なる光を照射して得られる光を検出、情報処理して脈拍、体温、呼吸数等の生体信号を測定する装置及び方法が特許文献1で提案されている。
In this situation, it is necessary to establish a method that can detect signs of abnormalities in the simplest possible way just before any severe acute state is reached.
Therefore, conventionally, a measuring instrument is inserted into the ear, and the light obtained by irradiating the skin of the ear hole with light having a different wavelength is detected and processed to measure a biological signal such as pulse, body temperature, respiratory rate, etc. And a method have been proposed in US Pat.

特開2004−329928号公報JP 2004-329928 A

しかし、上記の特許文献1の従来例は、被験者における未病状態から病的状態を簡易に評価するものではなかった。
そこで、本発明は、被験者における未病状態から病的状態を簡易に評価する生体細胞機能の評価方法を提供することを目的とする。
However, the above-described conventional example of Patent Document 1 does not simply evaluate the pathological state from the non-disease state in the subject.
Then, an object of this invention is to provide the evaluation method of the biological cell function which evaluates a pathological state simply from the non-disease state in a test subject.

上記課題を解決するための本発明の生体細胞機能の評価方法は、被験者の脈拍を測定し、前記脈拍と同時に前記被験者の体温を測定し、前記脈拍を前記体温で除した値を求め、前記値により前記被験者における未病状態から病的状態を評価することを特徴とする。   The biological cell function evaluation method of the present invention for solving the above problems is to measure a subject's pulse, measure the subject's body temperature simultaneously with the pulse, determine a value obtained by dividing the pulse by the body temperature, The morbid state is evaluated from the non-disease state in the subject by the value.

本発明によれば、被験者における未病状態から病的状態を簡易に評価する。   According to the present invention, a morbid state is easily evaluated from an unaffected state in a subject.

本発明の実施形態における被験者の脈拍の経時的変化図である。It is a time-dependent change figure of the test subject's pulse in embodiment of this invention. 本発明の実施形態における被験者の体温の経時的変化図である。It is a time-dependent change figure of the test subject's body temperature in embodiment of this invention. 本発明の実施形態における被験者の脈拍を体温で除した値の経時的変化図である。It is a time-dependent change figure of the value which remove | divided the pulse of the test subject in embodiment of this invention by the body temperature. 本発明の実施形態における被験者の脈拍を体温で除した値と体温の相関図である。It is a correlation figure of the value which remove | divided the pulse of the test subject in embodiment of this invention by body temperature, and body temperature. 本発明の実施形態の構成図である。It is a block diagram of embodiment of this invention.

以下、添付図面を参照して、本発明の実施形態を説明する。
医療機関での検査を行う前の、被験者自身による検査ということでは、特別な検査機器、検査技術を利用せずに生体から情報を取り出す必要がある。医療機関を受診せずに生体情報を得る方法では、血圧などのバイタルサインが、この生体情報に該当し、バイタルサインは生体情報の中でも、生命兆候という基本的な情報を提供する。
Embodiments of the present invention will be described below with reference to the accompanying drawings.
In the case of a test by a subject before performing a test at a medical institution, it is necessary to extract information from a living body without using special test equipment and test technology. In a method of obtaining biological information without visiting a medical institution, vital signs such as blood pressure correspond to the biological information, and vital signs provide basic information such as vital signs among the biological information.

人間が日々、活動を行う時、生体は脳神経から最初の生体情報を全身に発信し、その情報を受け取りながら各臓器が独自の働きをしている。例えば、脳神経からの情報は心臓に送られ、心臓の拍動となって血流を生み出している。心臓の拍動にともなうバイタルサインは「心拍数」であり、さらに末梢では動脈の拍動として「脈拍」となる。さらに、この心臓からの血流は動脈壁への圧力を生じ、「血圧」という形で測定される。   When a human performs daily activities, the living body transmits the first biological information from the cranial nerve to the whole body, and each organ performs its own function while receiving the information. For example, information from the cranial nerves is sent to the heart, and it becomes the heartbeat to produce blood flow. The vital sign associated with the heartbeat is “heart rate”, and in the periphery, it becomes “pulse” as the arterial beat. Furthermore, this blood flow from the heart creates pressure on the arterial wall and is measured in the form of “blood pressure”.

また、細胞の生命活動に必要な酸素を取り込む活動は呼吸によって行われる。この呼吸の最初の臓器は肺であり、肺に関係するバイタルサインは「呼吸数」である。
血流にのって各臓器、細胞に運ばれるブドウ糖をはじめとする栄養素は、肺から血流に乗って臓器、細胞に運ばれる酸素を利用して燃焼(代謝)されてエネルギーATPを生み出す。
この時のATPは細胞の生命活動のエネルギー源として利用され、一部は熱として生体外へ放出される。この熱が「体温」となって検知されている。
In addition, the activity of taking in oxygen necessary for the vital activity of cells is performed by respiration. The first organ of this breath is the lung, and the vital sign associated with the lung is "respiration rate".
Nutrients such as glucose transported to each organ and cell along the bloodstream are burnt (metabolized) using oxygen transported from the lungs to the organ and cell through the bloodstream to generate energy ATP.
At this time, ATP is used as an energy source for the vital activity of cells, and part of it is released as heat to the outside of the living body. This heat is detected as “body temperature”.

以上の「心拍数」、もしくは「脈拍」、「血圧」、「呼吸数」、「体温」は基本的なバイタルサインとして、日常の診療の際に測定されている。これらのバイタルサインの測定は被験者に大きな負担が掛からず、現在では簡易測定器でも十分に正確な情報が得られる。この簡易測定器は、電子式血圧計、電子式体温計などとして市販もされている。これらを利用すれば、医療機関以外で各自のバイタルサインを測定することができる。また、測定毎に紙媒体やパソコンなどに記録していけば、経時的な変化を残すことができる。   The above “heart rate” or “pulse”, “blood pressure”, “respiration rate”, and “body temperature” are measured as basic vital signs during daily medical care. Measurement of these vital signs does not place a heavy burden on the subject, and at present, sufficiently accurate information can be obtained even with a simple measuring instrument. This simple measuring device is also commercially available as an electronic blood pressure monitor, an electronic thermometer, and the like. If these are used, each person's vital sign can be measured outside a medical institution. Moreover, if it records on a paper medium, a personal computer, etc. for every measurement, a temporal change can be left.

ただし、これまでのバイタルサインの測定値そのままの評価では、重大な病気の前兆をとらえることは難しい。言い換えれば、バイタルサインのデータそのままの生データでは、その情報内容に制限がある。そこで、従来から測定されて来たバイタルサインの一部を利用して、新しい評価項目を作った。
この新しい評価項目は、被験者の脈拍(Pulse rate)を同時に測定された体温(Body Temperature)で除した値である。脈拍は心臓の拍動である心拍数と同じものであり、自律神経によって支配されている。
However, it is difficult to detect a sign of a serious illness by evaluating the vital signs measured so far. In other words, there is a limit to the information content of raw data as it is as vital sign data. Therefore, a new evaluation item was created by using a part of vital signs that have been measured.
This new evaluation item is a value obtained by dividing the pulse rate of the subject by the body temperature (Body Temperature) measured simultaneously. The pulse is the same as the heart rate, which is the heartbeat, and is controlled by the autonomic nerve.

自律神経には交感神経、副交感神経があり、この二つの神経によって緊張と弛緩がコントロールされている。しかし、心拍数(脈拍)は自律神経の上位中枢である視床下部、扁桃体にも影響されている。特に扁桃体は種々の感情をキャッチする中枢であり、感情などの変化によって心拍数(脈拍)が変化する切掛けとなっている。さらに、この扁桃体は生体内で発生する乳酸に敏感に反応することも明らかになっている。
細胞内の細胞基質において、乳酸は解糖系でブドウ糖からピルビン酸を経て合成される。乳酸は十分な酸素が存在しない時に、ピルビン酸から合成される。生体内で酸素が不足する場合とは、激しい生理的運動時以外に炎症反応が起こる時などである。
Autonomic nerves include sympathetic nerves and parasympathetic nerves, and these two nerves control tension and relaxation. However, heart rate (pulse) is also affected by the hypothalamus and amygdala, which are the upper centers of the autonomic nerve. In particular, the amygdala is a center that catches various emotions, and it is the point that heart rate (pulse) changes due to changes in emotions. Furthermore, it has been revealed that the amygdala reacts sensitively to lactic acid generated in the living body.
In intracellular cellular substrates, lactic acid is synthesized from glucose via pyruvic acid in a glycolytic system. Lactic acid is synthesized from pyruvic acid when there is not enough oxygen present. The case where oxygen is deficient in a living body is when an inflammatory reaction occurs other than during intense physiological exercise.

生体内で正常な状態でも恒常性の維持のために、各種の化学反応がダイナミックに行われ、乳酸生成は変動している。そのため、正常な生理的状態でも乳酸値の変動に応じて、心拍数(脈拍)も変動している。しかし、組織、細胞が正常な恒常性を維持している時は、心拍数(脈拍)はある基準範囲の変動となる。
乳酸値が増加する炎症反応の場合、結果的に心拍数(脈拍)は基準値を超えて増加する可能性がある。この時の炎症反応には大きく二通りの反応がある。
第1の反応は、感染症、自己免疫疾患などのような体温上昇を伴う炎症反応で、発熱を伴うことが多い。
第2の反応は、感染症以外の炎症反応で、心筋梗塞、脳梗塞などの細胞の虚血性変化が生じる場合である。
In order to maintain homeostasis even in a normal state in a living body, various chemical reactions are performed dynamically, and lactic acid production varies. For this reason, even in a normal physiological state, the heart rate (pulse rate) varies according to the variation in the lactic acid level. However, when the tissues and cells maintain normal homeostasis, the heart rate (pulse) varies within a certain reference range.
In the case of an inflammatory reaction in which the lactic acid level increases, the heart rate (pulse) may consequently increase beyond the reference value. There are two main types of inflammatory reaction at this time.
The first reaction is an inflammatory reaction accompanied by an increase in body temperature such as an infectious disease or an autoimmune disease, and is often accompanied by fever.
The second reaction is a case where an ischemic change of a cell such as myocardial infarction or cerebral infarction occurs due to an inflammatory reaction other than an infection.

上記第1の反応と第2の反応の心拍数(脈拍)の変化を区別するために、心拍数(脈拍)変化とその反応に伴う発熱の有無を確認する。
そこで、本発明の実施形態においては、被験者の脈拍を測定する。さらに、この脈拍と同時に被験者の体温を測定する。次に、新しい指標として脈拍を体温で除した値を求め、この値により記被験者における未病状態から病的状態を評価する。
In order to distinguish the change in heart rate (pulse) between the first reaction and the second reaction, the heart rate (pulse) change and the presence or absence of fever associated with the reaction are confirmed.
Therefore, in the embodiment of the present invention, the pulse of the subject is measured. Furthermore, the body temperature of the subject is measured simultaneously with this pulse. Next, a value obtained by dividing the pulse by the body temperature is obtained as a new index, and the morbid state is evaluated from the non-disease state in the subject using this value.

さらに、本発明の実施形態は、図3、図4に示されるように脈拍を体温で除した値が基準範囲を逸脱した外れ値10と、徐々に変化を起こしている状況をとらえる変化点11と、外れ値10から変化点11の検出へと時系列が変化する時、繰り返す危険度を積算する積算危険度と、により被験者における未病状態から病的状態を評価する。   Furthermore, as shown in FIGS. 3 and 4, the embodiment of the present invention has an outlier 10 in which the value obtained by dividing the pulse by the body temperature deviates from the reference range, and a change point 11 that captures a situation in which the value gradually changes. Then, when the time series changes from the outlier 10 to the detection of the change point 11, the pathological state is evaluated from the non-disease state in the subject by the cumulative risk level that integrates the repeated risk levels.

臨床における脈拍変化、体温変化、さらに脈拍を体温で除した値の変化を経時的にプロットしたものを図1、2、3に示す。
さらに、体温と脈拍を体温で除した値の相関図を図4に示す。37℃以上のでは体温上昇と共に脈拍を体温で除した値も増加し、図4(37℃以上)は感染症、自己免疫疾患などのような体温上昇を伴う第1の反応である炎症反応を示す。
一方、第2の反応は、図4(37℃以下)で体温が大きく上昇せずに、脈拍を体温で除した値が増加する。大きな体温上昇を伴わずに乳酸値が増加する場合、多くは細胞における酸素不足、すなわち、心筋梗塞、脳梗塞などの虚血性変化が生じている。
以上の第1の反応あるいは第2の反応を検知した時に、第1の反応と第2の反応を体温変化で区別し、被験者に生体情報としてのアラーム情報を伝達し、虚血性疾患の発病を予知する。
1, 2, and 3 are plots of changes in pulse values, body temperature changes, and changes in values obtained by dividing the pulse by body temperature over time.
Furthermore, a correlation diagram of values obtained by dividing body temperature and pulse by body temperature is shown in FIG. When the temperature is over 37 ° C., the value obtained by dividing the pulse by the body temperature increases as the body temperature rises. FIG. 4 (above 37 ° C.) Show.
On the other hand, in the second reaction, the value obtained by dividing the pulse by the body temperature does not increase significantly in FIG. 4 (37 ° C. or lower). When the lactic acid level increases without a large increase in body temperature, oxygen deficiency in the cells, that is, ischemic changes such as myocardial infarction and cerebral infarction have occurred.
When the first reaction or the second reaction is detected, the first reaction and the second reaction are distinguished by changes in body temperature, alarm information as biological information is transmitted to the subject, and the onset of ischemic disease is detected. Foresee.

本発明の実施形態の生体細胞機能の評価方法おける装置の全体構成図を図5に示す。
測定器1aは、被験者1の脈拍を測定し、脈拍と同時に被験者1の体温を測定する装置である。携帯電話3は、測定器1aにより測定された脈拍及び体温をコンピュータ4へ送信する。コンピュータ4は、脈拍を体温で除した値を求め、前記値により被験者1における未病状態から病的状態を評価する。コンピュータプログラム4aは、コンピュータ4のハードディスクである記録媒体4bに記録され、コンピュータ4の動作を制御する。コンピュータプログラムが記録される記録媒体は、CD−ROM等のあらゆる記録媒体を含み、ドライブ4cにCD−ROMが挿入され、さらに、コンピュータプログラム4aが、ハードディスクである記録媒体4bにインストールされて記録される。
FIG. 5 shows an overall configuration diagram of an apparatus in the biological cell function evaluation method according to the embodiment of the present invention.
The measuring device 1a is a device that measures the pulse of the subject 1 and measures the body temperature of the subject 1 simultaneously with the pulse. The mobile phone 3 transmits the pulse and body temperature measured by the measuring instrument 1a to the computer 4. The computer 4 obtains a value obtained by dividing the pulse by the body temperature, and evaluates a morbid state from an unaffected state in the subject 1 based on the value. The computer program 4 a is recorded on a recording medium 4 b that is a hard disk of the computer 4 and controls the operation of the computer 4. The recording medium on which the computer program is recorded includes any recording medium such as a CD-ROM, the CD-ROM is inserted into the drive 4c, and the computer program 4a is installed and recorded on the recording medium 4b which is a hard disk. The

また、図5に示されるように被験者1自身が、測定器1aを用いて脈拍及び体温を測定する。被験者1の体内での虚血性変化である心筋梗塞および/または脳梗塞を検知する。被験者1の体内での炎症反応である感染症および/または自己免疫疾患を検知する場合もある。虚血性変化および/または炎症反応を検知した時に図5に示されるように被験者1にアラーム情報5を伝達する。   Further, as shown in FIG. 5, the subject 1 himself / herself measures the pulse and body temperature using the measuring device 1a. A myocardial infarction and / or cerebral infarction that is an ischemic change in the body of the subject 1 is detected. In some cases, an infectious disease and / or an autoimmune disease that is an inflammatory reaction in the body of the subject 1 may be detected. When an ischemic change and / or an inflammatory reaction is detected, alarm information 5 is transmitted to the subject 1 as shown in FIG.

被験者1のバイタルサイン情報である脈拍および体温2を、被験者1自身が測定器1aにより測定し、携帯電話3を通じて定期的にサンプリングして、医療機関または検査機関のコンピュータ4に時系列データとして蓄積する。経時的に脈拍と体温がコンピュータ4に送られてくる度に、脈拍を体温で除した値を計算して時系列データに追加する。その過程で脈拍を体温で除した値が恒常的な基準範囲を逸脱して図3に示される外れ値10となった時に、何らかの異常がキャッチされるようにする。但し、その際に図4に示されるように体温上昇を伴うか、伴わないかの区別をしなければならない。外れ値10は被験者1にアラーム情報5として伝達される。   The pulse 1 and the body temperature 2 which are vital signs information of the subject 1 are measured by the subject 1 himself with the measuring device 1a, periodically sampled through the mobile phone 3, and stored as time series data in the computer 4 of the medical institution or the inspection institution. To do. Each time the pulse and body temperature are sent to the computer 4 over time, a value obtained by dividing the pulse by the body temperature is calculated and added to the time series data. In the process, when the value obtained by dividing the pulse by the body temperature deviates from the constant reference range and becomes the outlier 10 shown in FIG. 3, some abnormality is caught. However, at that time, as shown in FIG. 4, it is necessary to distinguish whether there is an increase in body temperature or not. The outlier 10 is transmitted to the subject 1 as alarm information 5.

さらに、外れ値10のような突発的な変化ではなく、徐々に変化を起こしている状況を適当な段階から変化点11として検出してアラームを鳴らす。最初に外れ値10で異常が検出されるが、その外れ値10がそれほど大きな変化でなければ、つい軽視してしまう恐れがある。このような穏やかな変化の検出に変化点11が重要となる。この変化点11もアラーム情報5として被験者1に伝達される。
何度か断続的な外れ値10の変化を示しながら、次第に連続的な変化を示すようになる場合は変化点11の検出によって異常を検知することができる。
Further, not a sudden change such as an outlier 10, but a situation where a change is gradually occurring is detected as a change point 11 from an appropriate stage and an alarm is sounded. First, an abnormality is detected with an outlier 10, but if the outlier 10 is not so large, there is a risk of neglecting it. The change point 11 is important for detecting such a gentle change. This change point 11 is also transmitted to the subject 1 as alarm information 5.
If a continuous change is gradually shown while showing an intermittent change of the outlier 10 several times, an abnormality can be detected by detecting the change point 11.

さらに、外れ値10から変化点11の検出へと時系列が変化する時、繰り返す危険度を積算しながら積算危険度のような評価値をアラーム情報5として被験者1に伝達する。
またこれらデータは定期的に、被験者1に要注意点を追加してレポート6として伝達される。
Further, when the time series changes from the outlier 10 to the detection of the change point 11, the evaluation value such as the integrated risk is transmitted to the subject 1 as the alarm information 5 while integrating the repeated risks.
In addition, these data are periodically transmitted to the subject 1 as a report 6 with points to be noted.

1 被験者 1a 測定器
2 脈拍・体温 3 携帯電話
4 コンピュータ 4a コンピュータプログラム
4b 記録媒体 4c ドライブ
5 アラーム情報 6 レポート
10 外れ値 11 変化点
1 Subject 1a Measuring instrument 2 Pulse / Body temperature 3 Mobile phone
4 Computer 4a Computer program 4b Recording medium 4c Drive 5 Alarm information 6 Report
10 Outlier 11 Change point

Claims (11)

被験者の脈拍を測定し、
前記脈拍と同時に前記被験者の体温を測定し、
前記脈拍を前記体温で除した値を求め、
前記値により前記被験者における未病状態から病的状態を評価することを特徴とする生体細胞機能の評価方法。
Measure the subject's pulse,
Measure the subject's temperature at the same time as the pulse,
Find the pulse divided by the body temperature,
A method for evaluating a biological cell function, wherein a pathological state is evaluated from an unaffected state in the subject based on the value.
前記値が基準範囲を逸脱した外れ値と、
徐々に変化を起こしている状況をとらえる変化点と、
前記外れ値から前記変化点の検出へと時系列が変化する時、繰り返す危険度を積算する積算危険度と、により前記被験者における未病状態から病的状態を評価することを特徴とする請求項1に記載の生体細胞機能の評価方法。
An outlier that deviates from the reference range, and
Change points to capture the situation that is gradually changing,
The pathological state of the subject is evaluated from an unaffected state based on an accumulated risk level that accumulates repeated risk levels when the time series changes from the outlier to the detection of the change point. 2. The method for evaluating a biological cell function according to 1.
前記被験者自身が、測定器を用いて前記脈拍及び前記体温を測定することを特徴とする請求項1または2に記載の生体細胞機能の評価方法。   The method for evaluating a biological cell function according to claim 1, wherein the subject himself / herself measures the pulse and the body temperature using a measuring instrument. 前記被験者の体内での虚血性変化である心筋梗塞および/または脳梗塞を検知することを特徴とする請求項1から3のいずれかに記載の生体細胞機能の評価方法。   4. The method for evaluating biological cell function according to claim 1, wherein myocardial infarction and / or cerebral infarction, which is an ischemic change in the body of the subject, is detected. 前記被験者の体内での炎症反応である感染症および/または自己免疫疾患を検知することを特徴とする請求項1から3のいずれかに記載の生体細胞機能の評価方法。   4. The method for evaluating a biological cell function according to claim 1, wherein an infectious disease and / or an autoimmune disease which is an inflammatory reaction in the body of the subject is detected. 前記虚血性変化および/または炎症反応を検知した時に前記被験者にアラーム情報を伝達することを特徴とする請求項4または5に記載の生体細胞機能の評価方法。   6. The biological cell function evaluation method according to claim 4, wherein alarm information is transmitted to the subject when the ischemic change and / or inflammatory reaction is detected. 請求項1から6のいずれかに記載の生体細胞機能の評価方法において、
前記被験者の前記脈拍を測定し、前記脈拍と同時に前記被験者の体温を測定することを特徴とする測定器。
The biological cell function evaluation method according to any one of claims 1 to 6,
A measuring instrument that measures the pulse of the subject and measures the temperature of the subject simultaneously with the pulse.
請求項1から6のいずれかに記載の生体細胞機能の評価方法において、
前記脈拍を前記体温で除した値を求め、前記値により前記被験者における未病状態から病的状態を評価することを特徴とするコンピュータ。
The biological cell function evaluation method according to any one of claims 1 to 6,
A computer which calculates | requires the value which remove | divided the said pulse by the said body temperature, and evaluates a pathological state from the non-disease state in the said test subject by the said value.
請求項8記載のコンピュータの動作を制御することを特徴とするコンピュータプログラム。   A computer program for controlling the operation of the computer according to claim 8. 請求項9記載のコンピュータプログラムを記録することを特徴とする記録媒体。   A recording medium for recording the computer program according to claim 9. 請求項7記載の測定器により測定された前記脈拍及び前記体温を請求項8記載のコンピュータへ送信することを特徴とする携帯電話。
A mobile phone that transmits the pulse and the body temperature measured by the measuring device according to claim 7 to the computer according to claim 8.
JP2009186569A 2009-08-11 2009-08-11 Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone Pending JP2011036416A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009186569A JP2011036416A (en) 2009-08-11 2009-08-11 Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009186569A JP2011036416A (en) 2009-08-11 2009-08-11 Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone

Publications (1)

Publication Number Publication Date
JP2011036416A true JP2011036416A (en) 2011-02-24

Family

ID=43764850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009186569A Pending JP2011036416A (en) 2009-08-11 2009-08-11 Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone

Country Status (1)

Country Link
JP (1) JP2011036416A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517758A (en) * 2011-05-26 2014-07-24 コーニンクレッカ フィリップス エヌ ヴェ Fever detection device
JP2016040693A (en) * 2014-08-13 2016-03-24 日本光電工業株式会社 Disease prediction device, disease prediction method, and disease prediction program
JP2019048061A (en) * 2018-09-26 2019-03-28 株式会社メディプリーム Disease prediction network system
CN114061053A (en) * 2021-11-03 2022-02-18 青岛海尔空调器有限总公司 Method and device for controlling air conditioning equipment and air conditioning equipment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004141281A (en) * 2002-10-23 2004-05-20 A & D Co Ltd Instrument and method for circulatory kinetics measurement
JP2005034391A (en) * 2003-07-15 2005-02-10 Takuya Shinkawa Sound outputting device and sound outputting method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004141281A (en) * 2002-10-23 2004-05-20 A & D Co Ltd Instrument and method for circulatory kinetics measurement
JP2005034391A (en) * 2003-07-15 2005-02-10 Takuya Shinkawa Sound outputting device and sound outputting method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013040391; 古谷伸之: '第2回体温・発熱を極める!' レジデント 2008年5月号, 200805, P. 6-12, 医学出版 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517758A (en) * 2011-05-26 2014-07-24 コーニンクレッカ フィリップス エヌ ヴェ Fever detection device
US9924879B2 (en) 2011-05-26 2018-03-27 Koninklijke Philips N.V. Fever detection apparatus
JP2016040693A (en) * 2014-08-13 2016-03-24 日本光電工業株式会社 Disease prediction device, disease prediction method, and disease prediction program
JP2019048061A (en) * 2018-09-26 2019-03-28 株式会社メディプリーム Disease prediction network system
CN114061053A (en) * 2021-11-03 2022-02-18 青岛海尔空调器有限总公司 Method and device for controlling air conditioning equipment and air conditioning equipment

Similar Documents

Publication Publication Date Title
Breteler et al. Vital signs monitoring with wearable sensors in high-risk surgical patients: a clinical validation study
Weenk et al. Continuous monitoring of vital signs using wearable devices on the general ward: pilot study
Tomasic et al. Continuous remote monitoring of COPD patients—justification and explanation of the requirements and a survey of the available technologies
White et al. Behavioral and physiological responsivity, sleep, and patterns of daily cortisol production in infants with and without colic
White et al. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension
Alharbi et al. Data management and wearables in older adults: A systematic review
Graham et al. Associations between heart rate variability measured with a wrist-worn sensor and older adults’ physical function: observational study
Ungar et al. Isolated ambulatory hypertension is common in outpatients referred to a hypertension centre
Purnell et al. Free-running circadian breathing rhythms are eliminated by suprachiasmatic nucleus lesion
Plekhanova et al. Validation of an automated sleep detection algorithm using data from multiple accelerometer brands
CN111741708A (en) System and method for analyzing biochemical sensor data
JP2011036416A (en) Method for evaluation of biological cell function, measuring instrument, computer, computer program, recording medium, and cellular phone
Derbin et al. Actigraphy: Metrics reveal it is not a valid tool for determining sleep in neonates
Zhu et al. Estimation of sleep quality of residents in nursing homes using an internet-based automatic monitoring system
Hwu et al. A study of the effectiveness of different measuring times and counting methods of human radial pulse rates
da Silva et al. Association between physical activity measurements and key parameters of cardiopulmonary exercise testing in patients with heart failure
Megalingam et al. MediSuit: Wearable health monitoring system for elders and bed-ridden patients
JP2022001966A (en) Information processing method, program and information processing device
Wowdzia et al. Glycemic response to acute high‐intensity interval versus moderate‐intensity continuous exercise during pregnancy
Hernandez-Meza et al. Investigation of data-driven optical neuromonitoring approach during general anesthesia with sevoflurane
Wells et al. Management of the acutely ill and medically complex older patient
Abdou et al. Evaluating a novel infant heart rate detector for neonatal resuscitation efforts: protocol for a proof-of-concept study
Larkin et al. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure
Redeker Challenges and opportunities associated with studying sleep in critically ill adults
van Rossum et al. Early warning scores to support continuous wireless vital sign monitoring for complication prediction in patients on surgical wards: retrospective observational study

Legal Events

Date Code Title Description
A621 Written request for application examination

Effective date: 20120731

Free format text: JAPANESE INTERMEDIATE CODE: A621

A977 Report on retrieval

Effective date: 20130729

Free format text: JAPANESE INTERMEDIATE CODE: A971007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130821

A02 Decision of refusal

Effective date: 20140108

Free format text: JAPANESE INTERMEDIATE CODE: A02